Relation between cholinesterase inhibitor and Pisa syndrome

Lancet

Volumn 355, Issue 9222, 2000, Pages 2222-

  Kwak, Yong Tae ^a   Han, Ii Woo ^a   Baik, Jongsam ^a   Koo, Min Seong ^b  

^a Department of Neurology   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; RISPERIDONE; RIVASTIGMINE;

ADULT; AGED; ALZHEIMER DISEASE; CASE REPORT; DRUG WITHDRAWAL; DYSTONIA; FEMALE; HUMAN; LETTER; PISA SYNDROME; PRIORITY JOURNAL;

EID: 0342699486     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02412-0     Document Type: Article

References (4)

1. Ekbom K., Lindholm H., Ljungberg L. New dystonic syndrome associated with butyrophenone therapy. J Neurol. 202:1972;94-103.
2. Remington G.J. The Pisa syndrome. possible role for serotonin and noradrenaline J Clin Psychopharmacol. 8:1988;228-229.
3. Suzuki T., Koizumi J., Moroji T., Sakuma K., Hori M., Hori T. Clinical characteristics of the Pisa syndrome. Acta Psychiatr Scand. 82:1990;454-457.
4. Suzuki T., Hori T., Baba A.et al. Effectiveness of anticholinergics and neuroleptic dose reduction on neuroleptic-induced pleurothotonus (the Pisa Syndrome). J Clin Psychopharmacol. 19:1999;277-280.